[ad_1]
‘What is absolutely essential is that we have a high vaccination rate before the autumn / winter of next year,’ said Professor Ugur Sahin.
The general manager of the German company BioNTech, which has developed a vaccine against the new coronavirus with Pfizer, spoke on Sunday of a possible return to normal by next winter.
“If all goes well, we will start administering the vaccine at the end of this year,” said the prof. Ugur Sahin. “Our goal is to deliver more than 300 million doses of the vaccine until April next year, which would allow us to start making an impact” against the virus, which has killed more than 1.3 million worldwide.
Take action before next fall
“The biggest impact will happen until the summer. Summer will help us anyway as the infection rate will drop, ”he continued. “What is absolutely essential is that we have a significant vaccination rate before the fall / winter of next year.”
“I am confident it will happen” because many vaccine manufacturers have been asked to increase production, he said, adding, “We could have a normal winter next year.”
According to Pfizer and BioNTech, their vaccine is “90% effective” against Covid-19, according to the ongoing large-scale Phase 3 trial, the last step before an application for approval.
Several other vaccines are also in this phase of research, suggesting the horizon for a return to normal.
.
[ad_2]
Source link
